Method for treating neurocardiogenic syncope

Details Method for treating neurocardiogenic syncope Method for treating neurocardiogenic syncope

1996-06-06

1998-01-13

Millin, Vincent

Surgery

Miscellaneous

Methods

514220, 514338, A61B 1900

Patent

active

057068291

ABSTRACT:
The present invention relates to methods for treating neurocardiogenic syncope. The method involves administering to a patient an effective amount of a compound having the formula: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.5 are each selected from the group consisting of hydrogen and lower alkyl; and R.sub.3 and R.sub.4 are each selected from the group consisting of hydrogen, halogen, lower alkyl, nitro, amino, trifluoromethyl, and lower acylamino; at least one of R.sub.3 and R.sub.4 being a nitrogen containing group,
or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 3116203 (1963-12-01), Kariss et al.
patent: 3121114 (1964-02-01), Keller et al.
patent: 3123529 (1964-03-01), Kariss et al.
patent: 3203990 (1965-08-01), Keller et al.
patent: 3335181 (1967-08-01), Focella et al.
patent: 4472397 (1984-09-01), Lahti et al.
patent: 4772599 (1988-09-01), Watjen
patent: 5284491 (1994-02-01), Sutton et al.
patent: 5302715 (1994-04-01), Buechler et al.
patent: 5317018 (1994-05-01), Walser et al.
patent: 5409946 (1995-04-01), Garvey et al.
patent: 5501701 (1996-03-01), Markowitz et al.
Goodman and Gilman, "The Pharmacological Basis of Therapeutics" fourth edition. pp. 177-181, 1970.
Sugimoto, et al. "The effects of diazepam on rat isolated heart muscle." Clinical and Experimental Pharmacology and Physiology. 5:655-663, 1978.
Defeudis, F.V. "GABA and `neuro-cardiovascular` mechanisms." Neurochemistry International. 3(2): 113-121, 1981.
Petersdorf, et al, eds. "Harrison's Principles of Internal Medicine." 1983. pp: 76-80, 1298, 2025-2027, 2106, 1983.
Raza, et al. "Comparison of the hemodynamic effects of midazolam and diazepam in patients with coronary occlusion." International Journal of Clinical Pharmacology, Therapy and Toxicology, 27(Jan. 1989): 1-6, 1989.
Osman, et al. "Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humans." Psychopharmacology. 111:295-300, 1993.
Abi-Samra et al., Pacing Clin Electrophysiol 11(8): 1202-1214 (1988).
Fitzpatrick et al., Pacing Clin Electrophysiol 13(5): 619-624 (1991).
Kapoor, JAMA 268(18): 2553-2560 (1992).
Kenny et al., Lancet 1(8494): 1352-1355 (1986).
Kosinski et al., Pacing Clin Electrophysiol 18(4 Pt 1): 716-724 (1995).
Lipton and Forstater, J Emerg Med 11(6): 723-727 (1993).
Milstein et al., Am J Cardiol 65(20): 1339-1344 (1990).
Natale et al., Pacing Clin Electrophysiol 18(4 Pt 1): 655-662 (1995).
Sra et al., Cardiol Clin 11(1): 183-191 (1993).
Sra et al., N Engl J Med 328(15): 1085-1090 (1993).
Sternbach et al., J Med Chem 6:261-265 (1963).
Sato and Malow, in Antiepileptic Drugs, 4th Edition, edited by R.H. Levy et al., Raven Press, Ltd., New York, pp. 725-734 (1995).
The Merch Index, 10th Edition, edited by W. Windholz et al., Merck & Co., Inc., Rahway, New Jersey, p. 2351 #2352 (1983).
The Physicians' Desk Reference, 39th Edition, publisher E.R. Barnhart, Medical Economics Company Inc., Oradell, New Jersey pp. 429, 1680-1681 (1985).
Kadri et al., Abstract from the 17th Annual Meeting of the North American Society of Pacing and Electrophysiology, published Apr. 1996.

Affiliated with

Also associated with

Rating

Method for treating neurocardiogenic syncope does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating neurocardiogenic syncope, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating neurocardiogenic syncope will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-318706